201 related articles for article (PubMed ID: 32767345)
1. Is mesalazine treatment effective in the prevention of diverticulitis? A review.
Stefanelli G; Viscido A; Valvano M; Vernia F; Frieri G; Ashktorab H; Latella G
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8164-8176. PubMed ID: 32767345
[TBL] [Abstract][Full Text] [Related]
2. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials.
Khan RMA; Ali B; Hajibandeh S; Hajibandeh S
Colorectal Dis; 2018 Jun; 20(6):469-478. PubMed ID: 29520987
[TBL] [Abstract][Full Text] [Related]
3. Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials.
Picchio M; Elisei W; Brandimarte G; Di Mario F; Malfertheiner P; Scarpignato C; Tursi A
J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S64-9. PubMed ID: 27622370
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
[TBL] [Abstract][Full Text] [Related]
5. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
Tursi A; Papa A; Danese S
Aliment Pharmacol Ther; 2015 Sep; 42(6):664-84. PubMed ID: 26202723
[TBL] [Abstract][Full Text] [Related]
6. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
Iannone A; Ruospo M; Wong G; Barone M; Principi M; Di Leo A; Strippoli GFM
Can J Gastroenterol Hepatol; 2018; 2018():5437135. PubMed ID: 30320044
[TBL] [Abstract][Full Text] [Related]
7. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
Picchio M; Elisei W; Tursi A
J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
[TBL] [Abstract][Full Text] [Related]
8. Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.
Tursi A; Joseph RE; Streck P
Dig Dis Sci; 2011 Nov; 56(11):3112-21. PubMed ID: 21567193
[TBL] [Abstract][Full Text] [Related]
9. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
Maconi G; Barbara G; Bosetti C; Cuomo R; Annibale B
Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.
Tursi A; Brandimarte G; Elisei W; Picchio M; Forti G; Pianese G; Rodino S; D'Amico T; Sacca N; Portincasa P; Capezzuto E; Lattanzio R; Spadaccini A; Fiorella S; Polimeni F; Polimeni N; Stoppino V; Stoppino G; Giorgetti GM; Aiello F; Danese S
Aliment Pharmacol Ther; 2013 Oct; 38(7):741-51. PubMed ID: 23957734
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.
Kruis W; Kardalinos V; Eisenbach T; Lukas M; Vich T; Bunganic I; Pokrotnieks J; Derova J; Kondrackiene J; Safadi R; Tuculanu D; Tulassay Z; Banai J; Curtin A; Dorofeyev AE; Zakko SF; Ferreira N; Björck S; Diez Alonso MM; Mäkelä J; Talley NJ; Dilger K; Greinwald R; Mohrbacher R; Spiller R
Aliment Pharmacol Ther; 2017 Aug; 46(3):282-291. PubMed ID: 28543263
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.
Gatta L; Di Mario F; Curlo M; Vaira D; Pilotto A; Lucarini P; Lera M; Enkleda K; Franzé A; Scarpignato C
Intern Emerg Med; 2012 Apr; 7(2):133-7. PubMed ID: 21279478
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of 5-ASA in the treatment of colonic diverticular disease.
Gatta L; Vakil N; Vaira D; Pilotto A; Curlo M; Comparato G; Leandro G; Ferro U; Lera M; Milletti S; Di Mario F
J Clin Gastroenterol; 2010 Feb; 44(2):113-9. PubMed ID: 19561530
[TBL] [Abstract][Full Text] [Related]
14. 5-aminosalicylic acid agents for prevention of recurrent diverticulitis: A systematic review and meta-analysis.
Urushidani S; Kuriyama A; Matsumura M
J Gastroenterol Hepatol; 2018 Jan; 33(1):12-19. PubMed ID: 28623877
[TBL] [Abstract][Full Text] [Related]
15. Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease.
Cuomo R; Cargiolli M; Andreozzi P; Zito FP; Sarnelli G
Minerva Gastroenterol Dietol; 2017 Jun; 63(2):130-142. PubMed ID: 27973463
[TBL] [Abstract][Full Text] [Related]
16. Hot Topics in Medical Treatment of Diverticular Disease: Evidence Pro and Cons.
Brandimarte G; Bafutto M; Kruis W; Scarpignato C; Mearin F; Barbara G; Štimac D; Vranić L; Cassieri C; Lecca PG; D'Avino A; Malfertheiner P
J Gastrointestin Liver Dis; 2019 Dec; 28(suppl. 4):23-29. PubMed ID: 31930227
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of medical therapy to prevent recurrent diverticulitis.
Unlü C; Daniels L; Vrouenraets BC; Boermeester MA
Int J Colorectal Dis; 2012 Sep; 27(9):1131-6. PubMed ID: 22576905
[TBL] [Abstract][Full Text] [Related]
18. Diverticulosis today.
Elisei W; Brandimarte G; Tursi A
Minerva Gastroenterol Dietol; 2019 Mar; 65(1):42-52. PubMed ID: 30293416
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.
Tursi A; Brandimarte G; Daffinà R
Dig Liver Dis; 2002 Jul; 34(7):510-5. PubMed ID: 12236485
[TBL] [Abstract][Full Text] [Related]
20. Mesalazine for diverticular disease of the colon--a new role for an old drug.
Tursi A
Expert Opin Pharmacother; 2005 Jan; 6(1):69-74. PubMed ID: 15709884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
